Skip to content

Effects and Mechanisms of Liuzijue Combined with Respiratory Muscle Training on Respiratory Dysfunction in Parkinson's Disease

Effects and Mechanisms of Liuzijue Combined with Respiratory Muscle Training on Respiratory Dysfunction in Parkinson's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117296
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-02-15
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Liuzijue Combined with Respiratory Muscle Training Group:Liuzijue Combined with Respiratory Muscle Training
Respiratory Muscle Training Group :Respiratory Muscle Training
Control Group :Conventional Rehabilitation Training

Sponsors

Shanghai Yangzhi rehabilitation hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria for PD patients: (1) Diagnosed with primary Parkinson's disease by a specialist according to the MDS 2015 diagnostic criteria, aged 55-80 years; (2) Hoehn-Yahr (H-Y) disease stage 1-4; (3) Receiving Parkinson's disease medication with stable condition, and no adjustment to the medication regimen within 3 months after enrollment; (4) No significant cognitive impairment (MoCA >= 20 points); (5) Voluntary participation and signed informed consent. 2. Inclusion criteria for healthy control group: (1) Aged 55-80 years; (2) Able to understand and respond to instructions given in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with cognitive impairment (MoCA <20); 2. Patients with a history of lung surgery, recent respiratory infection, or other lung diseases confirmed by imaging; 3. Patients with unstable cardiovascular disease; 4. Patients with mental illness or other serious illnesses.

Design outcomes

Primary

MeasureTime frame
Maximum Expiratory Pressure;

Secondary

MeasureTime frame
Lung Volumes;The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Score;Maximal Inspiratory Pressure;Parkinson's Disease Questionnaire (PDQ-39);6-minute walk test;Thoracic Mobility;Vital Capacity;Maximum Voluntary Ventilation;Diaphragmatic Ultrasound;Respiratory Muscle Surface Electromyography;

Countries

China

Contacts

Public ContactQing Zhao

Shanghai Yangzhi rehabilitation hospital

qingzhao2010@hotmail.com+86 21 37730011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026